NYSE:CHE - Chemed Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $328.16 +0.15 (+0.05 %) (As of 07/20/2018 04:00 PM ET)Previous Close$328.01Today's Range$326.98 - $330.0052-Week Range$186.09 - $335.99Volume131,000 shsAverage Volume156,872 shsMarket Capitalization$5.23 billionP/E Ratio61.17Dividend Yield0.34%Beta1.12 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio. Receive CHE News and Ratings via Email Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Home health care services Sub-IndustryHealth Care Services SectorMedical SymbolNYSE:CHE CUSIP16359R10 Webwww.chemed.com Phone513-762-6690 Debt Debt-to-Equity Ratio0.26 Current Ratio0.91 Quick Ratio0.88 Price-To-Earnings Trailing P/E Ratio61.17 Forward P/E Ratio29.94 P/E Growth2.99 Sales & Book Value Annual Sales$1.67 billion Price / Sales3.14 Cash Flow$7.9767 per share Price / Cash41.14 Book Value$33.84 per share Price / Book9.70 Profitability EPS (Most Recent Fiscal Year)$5.36 Net Income$98.17 million Net Margins6.67% Return on Equity33.05% Return on Assets17.97% Miscellaneous Employees14,813 Outstanding Shares15,940,000Market Cap$5,226.12 Chemed (NYSE:CHE) Frequently Asked Questions What is Chemed's stock symbol? Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE." How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed announced a quarterly dividend on Monday, May 21st. Shareholders of record on Thursday, May 31st will be given a dividend of $0.28 per share on Wednesday, June 20th. This represents a $1.12 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date is Wednesday, May 30th. View Chemed's Dividend History. How will Chemed's stock buyback program work? Chemed declared that its board has approved a stock buyback plan on Wednesday, March 7th 2018, which authorizes the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) announced its earnings results on Thursday, April, 19th. The company reported $2.72 earnings per share for the quarter, beating analysts' consensus estimates of $2.36 by $0.36. The business earned $439.18 million during the quarter, compared to the consensus estimate of $419.33 million. Chemed had a return on equity of 33.05% and a net margin of 6.67%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.82 earnings per share. View Chemed's Earnings History. When is Chemed's next earnings date? Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Chemed. What price target have analysts set for CHE? 3 brokerages have issued 12-month target prices for Chemed's shares. Their predictions range from $258.00 to $275.00. On average, they anticipate Chemed's stock price to reach $266.50 in the next year. This suggests that the stock has a possible downside of 18.8%. View Analyst Ratings for Chemed. What is the consensus analysts' recommendation for Chemed? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." Are investors shorting Chemed? Chemed saw a decline in short interest in the month of June. As of June 15th, there was short interest totalling 544,322 shares, a decline of 32.5% from the May 31st total of 805,842 shares. Based on an average daily trading volume, of 374,162 shares, the short-interest ratio is presently 1.5 days. Currently, 3.5% of the company's shares are sold short. View Chemed's Current Options Chain. Who are some of Chemed's key competitors? Some companies that are related to Chemed include Amedisys (AMED), LHC Group (LHCG), Addus Homecare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL). Who are Chemed's key executives? Chemed's management team includes the folowing people: Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)Mr. David P. Williams, Exec. VP & CFO (Age 57)Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)Mr. Spencer S. Lee, Exec. VP (Age 62)Mr. Nicholas Michael Westfall, Exec. VP (Age 39) Has Chemed been receiving favorable news coverage? Media headlines about CHE stock have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Chemed earned a news impact score of 0.02 on Accern's scale. They also gave press coverage about the company an impact score of 45.38 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future. Who are Chemed's major shareholders? Chemed's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (3.17%), Fisher Asset Management LLC (3.01%), Retirement Systems of Alabama (0.25%), Clinton Group Inc. (0.07%), Palo Capital Inc. (0.07%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed. Which major investors are selling Chemed stock? CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Nisa Investment Advisors LLC, Louisiana State Employees Retirement System, Municipal Employees Retirement System of Michigan, State of Alaska Department of Revenue, Fisher Asset Management LLC, Cape Cod Five Cents Savings Bank and Palo Capital Inc.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed. Which major investors are buying Chemed stock? CHE stock was bought by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Clinton Group Inc., Bank of Montreal Can, Campbell & CO Investment Adviser LLC, Amalgamated Bank, Xact Kapitalforvaltning AB, Hartford Investment Management Co. and LS Investment Advisors LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed. How do I buy shares of Chemed? Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Chemed's stock price today? One share of CHE stock can currently be purchased for approximately $328.16. How big of a company is Chemed? Chemed has a market capitalization of $5.23 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe. How can I contact Chemed? Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690. MarketBeat Community Rating for Chemed (NYSE CHE)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 169 (Vote Outperform)Underperform Votes: 246 (Vote Underperform)Total Votes: 415MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: What is a closed-end mutual fund (CEF)?